[1] Brown AL, Kay GF. Bex1, a gene with increased expression in parthenogenetic embryos, is a member of a novel gene family on the mouse X chromosome. Hum Mol Genet, 1999, 8(4): 611-619.[2] Ryan SG, Chance PF, Zou CH, Spinner NB, Golden JA, Smietana S. Epilepsy and mental retardation limited to females: an X-linked dominant disorder with male sparing. Nat Genet, 1997, 17(1): 92-95.[3] Yang QS, Xia F, Gu SH, Yuan HL, Chen JZ, Yang QS, Ying K, Xie Y, Mao YM. Cloning and expression pattern of a spermatogenesis-related gene, BEX1, mapped to chromosome Xq22. Biochem Genet, 2002, 40(1-2): 1-12.[4] Behrens M, Margolis JW, Margolis FL. Identification of members of the Bex gene family as olfactory marker protein (OMP) binding partners. J Neuro-chem, 2003, 86(5): 1289-1296.[5] Vilar M, Murillo-Carretero M, Mira H, Magnusson K, Besset V, Ibáñez CF. Bex1, a novel interactor of the p75 neurotrophin receptor, links neurotrophin signaling to the cell cycle. EMBO J, 2006, 25(6): 1219-1230.[6] Foltz G, Ryu GY, Yoon JG, Nelson T, Fahey J, Frakes A, Lee H, Field L, Zander K, Sibenaller Z, Ryken TC, Vib-hakar R, Hood L, Madan A. Genome-wide analysis of epigenetic silencing identifies BEX1 and BEX2 as candi-date tumor suppressor genes in malignant glioma. Cancer Res, 2006, 66(13): 6665-6674.[7] Naderi A, Liu J, Bennett IC. BEX2 regulates mitochon-drial apoptosis and G1 cell cycle in breast cancer. Int J Cancer, 2010, 126(7): 1596-1610.[8] Kalpana GV, Marmon S, Wang W, Crabtree GR, Goff SP. Binding and stimulation of HIV-1 integrase by a human homolog of yeast transcription factor SNF5. Science, 1994, 266(5193): 2002-2006.[9] 吕湘, 刘德培, 梁植权. 染色质重塑复合物. 生命的化学, 2001, 21(2): 96-99.[10] Muchardt C, Sardet C, Bourachot B, Onufryk C, Yaniv M. A human protein with homology to Saccharomyces cerevisiae SNF5 interacts with the potential helicase hbrm. Nucleic Acids Res, 1995, 23(7): 1127-1132.[11] Kingston RE, Narlikar GJ. ATP-dependent remodeling and acetylation as regulators of chromatin fluidity. Genes Dev, 1999, 13(18): 2339-2352.[12] Cheng SW, Davies KP, Yung E, Beltran RJ, Yu J, Kalpana GV. c-MYC interacts with INI1/hSNF5 and requires the SWI/SNF complex for transactivation function. Nat Genet, 1999, 22(1): 102-105.[13] Zhang ZK, Davies KP, Allen J, Zhu L, Pestell RG, Zagzag D, Kalpana GV. Cell cycle arrest and repression of cyclin D1 transcription by INI1/hSNF5. Mol Cell Biol, 2002, 22(16): 5975-5988.[14] Rozenblatt-Rosen O, Rozovskaia T, Burakov D, Sedkov Y, Tillib S, Blechman J, Nakamura T, Croce CM, Mazo A, Canaani E. The C-terminal SET domains of ALL-1 and TRITHORAX interact with the INI1 and SNR1 proteins, components of the SWI/SNF complex. Proc Natl Acad Sci USA, 1998, 95(8): 4152-4157.[15] Wu DY, Krumm A, Schubach WH. Promoter-specific tar-geting of human SWI-SNF complex by Epstein-Barr virus nuclear protein 2. J Virol, 2000, 74(19): 8893-8903.[16] Lee D, Sohn H, Kalpana GV, Choe J. Interaction of E1 and hSNF5 proteins stimulates replication of human papillo-mavirus DNA. Nature, 1999, 399(6735): 487-491.[17] Adler HT, Chinery R, Wu DY, Kussick SJ, Payne JM, Fornace AJ Jr, Tkachuk DC. Leukemic HRX fusion pro-teins inhibit GADD34-induced apoptosis and associate with the GADD34 and hSNF5/INI1 proteins. Mol Cell Biol, 1999, 19(10): 7050-7060.[18] Morozov A, Yung E, Kalpana GV. Structure-function analysis of integrase interactor 1/hSNF5L1 reveals differential properties of two repeat motifs present in the highly conserved region. Proc Natl Acad Sci USA, 1998, 95(3): 1120-1125.[19] Versteege I, Sévenet N, Lange J, Rousseau-Merck MF, Ambros P, Handgretinger R, Aurias A, Delattre O. Trun-cating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature, 1998, 394(6689): 203 |